LV10924A - Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai - Google Patents
Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanaiInfo
- Publication number
- LV10924A LV10924A LV950158A LV950158A LV10924A LV 10924 A LV10924 A LV 10924A LV 950158 A LV950158 A LV 950158A LV 950158 A LV950158 A LV 950158A LV 10924 A LV10924 A LV 10924A
- Authority
- LV
- Latvia
- Prior art keywords
- treatment
- free radical
- disease prevention
- synthetic catalytic
- acceptors used
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 230000003078 antioxidant effect Effects 0.000 title abstract 2
- 239000000370 acceptor Substances 0.000 title 1
- 230000003197 catalytic effect Effects 0.000 title 1
- 230000006806 disease prevention Effects 0.000 title 1
- 150000003254 radicals Chemical class 0.000 title 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract 1
- 230000005779 cell damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/987,474 US5403834A (en) | 1992-12-07 | 1992-12-07 | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
PCT/US1993/011857 WO1994013300A1 (en) | 1992-12-07 | 1993-12-06 | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10924A true LV10924A (lv) | 1995-12-20 |
LV10924B LV10924B (en) | 1996-10-20 |
Family
ID=25533292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-95-158A LV10924B (en) | 1992-12-07 | 1995-06-06 | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
Country Status (20)
Country | Link |
---|---|
US (2) | US5403834A (lv) |
EP (2) | EP0746321B1 (lv) |
JP (1) | JP3502099B2 (lv) |
KR (1) | KR20040004386A (lv) |
AT (1) | ATE290867T1 (lv) |
AU (1) | AU697399B2 (lv) |
CA (1) | CA2150937C (lv) |
CZ (1) | CZ296288B6 (lv) |
DE (1) | DE69333775T2 (lv) |
GB (2) | GB2277873B (lv) |
HU (1) | HU225109B1 (lv) |
LV (1) | LV10924B (lv) |
NO (1) | NO319454B1 (lv) |
NZ (1) | NZ259200A (lv) |
OA (1) | OA10165A (lv) |
PL (1) | PL175446B1 (lv) |
RU (1) | RU2157213C2 (lv) |
SK (1) | SK74595A3 (lv) |
UA (1) | UA27949C2 (lv) |
WO (1) | WO1994013300A1 (lv) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5653685A (en) * | 1990-10-10 | 1997-08-05 | Lrt, Inc. | Method of providing circulation via lung expansion and deflation |
USRE36460E (en) * | 1990-10-10 | 1999-12-21 | Life Science Holdings, Inc. | Method of providing circulation via lung expansion and deflation |
US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5696109A (en) * | 1992-12-07 | 1997-12-09 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5834509A (en) * | 1992-12-07 | 1998-11-10 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US7582786B2 (en) * | 1992-12-07 | 2009-09-01 | Eukarion Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
US6245758B1 (en) | 1994-05-13 | 2001-06-12 | Michael K. Stern | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
HUT76327A (en) * | 1994-05-13 | 1997-08-28 | Monsanto Co | Pharmaceutical compositions catalyzing decomposition of peroxy-nitrite |
US5681278A (en) * | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
WO1996004311A1 (en) * | 1994-08-03 | 1996-02-15 | University Of Alabama At Birmingham Research Foundation | Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease |
US5900433A (en) * | 1995-06-23 | 1999-05-04 | Cormedics Corp. | Vascular treatment method and apparatus |
WO1997032621A1 (en) * | 1996-03-08 | 1997-09-12 | Life Resuscitation Technologies, Inc. | Liquid ventilation method and apparatus |
AU4258097A (en) | 1996-09-06 | 1998-03-26 | Duke University | Methods for testing compounds for use as therapeutic antioxidants |
US6369106B1 (en) * | 1996-12-26 | 2002-04-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Treatment of ischemic brain injuries with brain targeted anti oxidant compounds |
US6214817B1 (en) | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
US5834178C1 (en) * | 1997-07-09 | 2002-04-23 | Univ Wayne State | Flush-storage solution for donor organs |
US5829449A (en) * | 1997-09-19 | 1998-11-03 | Thione International, Inc. | Smoking products containing antioxidants |
AT409306B (de) * | 1997-10-03 | 2002-07-25 | Hoffmann La Roche | Optisch chemischer sensor |
ES2198767T3 (es) | 1997-11-03 | 2004-02-01 | Duke University | Porfirinas sustituidas. |
CA2249778A1 (en) * | 1997-12-15 | 1999-06-15 | Bayer Corporation | Competitive apo-peroxidase assay |
GB9817845D0 (en) | 1998-08-17 | 1998-10-14 | Glaxo Group Ltd | Chemical compounds |
US7816403B2 (en) * | 1998-09-08 | 2010-10-19 | University Of Utah Research Foundation | Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same |
US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
AU779283B2 (en) | 1999-01-25 | 2005-01-13 | Aeolus Sciences, Inc. | Substituted porphyrins |
US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US20040110722A1 (en) * | 1999-05-27 | 2004-06-10 | Ornberg Richard L. | Modified hyaluronic acid polymers |
US7445641B1 (en) * | 1999-05-27 | 2008-11-04 | Pharmacia Corporation | Biomaterials modified with superoxide dismutase mimics |
US6179804B1 (en) * | 1999-08-18 | 2001-01-30 | Oxypatch, Llc | Treatment apparatus for wounds |
RU2263672C2 (ru) * | 2000-02-11 | 2005-11-10 | Рисерч Дивелопмент Фаундейшн | Токоферолы, токотриенолы, другие хроманы и производные по боковым цепям и их применение |
US20040047852A1 (en) * | 2001-03-02 | 2004-03-11 | Kennedy Thomas Preston | Method of treating cancer |
US20030069281A1 (en) * | 2000-06-14 | 2003-04-10 | Irwin Fridovich | Tetrapyrroles |
WO2002043514A1 (en) * | 2000-11-28 | 2002-06-06 | Lorillard Licensing Company, Llc | A smoking article including a selective carbon monoxide pump |
US6481442B1 (en) | 2000-11-28 | 2002-11-19 | Lorillard Licensing Company, Llc | Smoking article including a filter for selectively removing carbonyls |
US6589948B1 (en) * | 2000-11-28 | 2003-07-08 | Eukarion, Inc. | Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
US6692458B2 (en) * | 2000-12-19 | 2004-02-17 | Edwards Lifesciences Corporation | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis |
DE60233317D1 (de) * | 2001-01-19 | 2009-09-24 | Nat Jewish Med & Res Center | Medikament zum schutz in der radiotherapie |
ITPI20010014A1 (it) * | 2001-03-05 | 2002-09-05 | Ivo Pera | Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto |
KR100681326B1 (ko) * | 2001-04-20 | 2007-02-15 | 주식회사 중외제약 | 신규한 망간-키랄성 화합물 및 그의 이용방법 |
CA2449024A1 (en) * | 2001-06-01 | 2002-12-12 | National Jewish Medical And Research Center | Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
WO2003010153A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
WO2003010143A1 (en) | 2001-07-26 | 2003-02-06 | Samsung Electronics Co., Ltd. | Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
WO2003010154A1 (en) | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
ATE468109T1 (de) * | 2001-12-19 | 2010-06-15 | Res Dev Foundation | Liposomale abgabe von verbindungen auf vitamin-e- basis |
EP1513537A4 (en) * | 2002-06-07 | 2006-09-06 | Univ Duke | SUBSTITUTED PORPHYRINS |
US6835387B2 (en) | 2002-06-11 | 2004-12-28 | Scimed Life Systems, Inc. | Sustained release of superoxide dismutase mimics from implantable or insertable medical devices |
US20040044220A1 (en) * | 2002-08-22 | 2004-03-04 | University Of Florida | Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
WO2004017959A2 (en) * | 2002-08-22 | 2004-03-04 | University Of Florida | Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
CN104587479A (zh) | 2002-12-09 | 2015-05-06 | 阿布拉西斯生物科学有限责任公司 | 组合物和传递药剂的方法 |
RU2361615C2 (ru) * | 2002-12-09 | 2009-07-20 | Абраксис Байосайенс, Ллс. | Композиции и способы доставки фармакологических агентов |
US7129035B2 (en) * | 2002-12-11 | 2006-10-31 | Cryolife, Inc. | Method of preserving tissue |
WO2005030137A2 (en) * | 2003-09-24 | 2005-04-07 | The University Of Toledo, A University Instrumentality Of The State Of Ohio | Improving biomechanical performance of irradiated biological material |
US20050100537A1 (en) * | 2003-11-10 | 2005-05-12 | Evans Gregory S. | Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals |
US20090099150A1 (en) * | 2005-01-19 | 2009-04-16 | Daniela Salvemini | Methotrexate Combinations For Treating Inflammatory Diseases |
ATE432086T1 (de) * | 2005-05-04 | 2009-06-15 | Coty Prestige Lancaster Group | Verwendung von freien radikalfängern zum schutz und zur behandlung von durch chemotherapie verursachten haut- und haarschäden |
EP2036550A4 (en) * | 2006-06-28 | 2009-07-15 | Ihi Corp | MEDICAMENT, DRUG DELIVERY DEVICE, MAGNETIC DETECTOR, AND DRUG DESIGN METHOD |
WO2008070557A2 (en) * | 2006-12-01 | 2008-06-12 | Women & Infants Hospital | Organometallic complexes as therapeutic agents |
US20090169484A1 (en) | 2007-12-28 | 2009-07-02 | Ihi Corporation | Iron-salen complex |
US11382895B2 (en) | 2008-05-23 | 2022-07-12 | National Jewish Health | Methods for treating injury associated with exposure to an alkylating species |
WO2010058280A1 (ja) * | 2008-11-20 | 2010-05-27 | 株式会社Ihi | 自己磁性金属サレン錯体化合物 |
KR101050273B1 (ko) * | 2008-11-21 | 2011-07-19 | 세종대학교산학협력단 | 살렌 전이금속 착화합물, 및 그 제조 방법 |
US9603940B2 (en) * | 2010-04-06 | 2017-03-28 | Ihi Corporation | Metal salen complex derivative and process for production thereof |
RU2547570C2 (ru) | 2010-04-28 | 2015-04-10 | АйЭйчАй КОРПОРЕЙШН | Лекарственное средство против опухоли головного мозга |
CN102918118A (zh) * | 2010-06-01 | 2013-02-06 | 株式会社Ihi | 荧光色素材料及其使用方法 |
US9005757B2 (en) * | 2010-12-21 | 2015-04-14 | Ihi Corporation | Metal-salen complex compound and method for producing the same |
JP5873656B2 (ja) | 2011-06-13 | 2016-03-01 | 株式会社Ihi | 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤 |
JP6017766B2 (ja) * | 2011-07-26 | 2016-11-02 | 株式会社Ihi | 新規な金属サレン錯体化合物の抗がん剤 |
SG11201401289YA (en) * | 2011-10-04 | 2014-07-30 | Ihi Corp | Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound |
JP6046338B2 (ja) * | 2011-10-27 | 2016-12-14 | 株式会社Ihi | ラジカル抑制剤 |
ES2683038T3 (es) * | 2012-01-05 | 2018-09-24 | Pledpharma Ab | Calmangafodipir, una nueva entidad química, y otros complejos metálicos mixtos, métodos de preparación, composiciones y métodos de tratamiento |
CN108030926B (zh) * | 2017-12-15 | 2021-07-13 | 武汉工程大学 | 一种具有高的SOD酶活性的Salen型锰配合物-壳聚糖复合材料及其制备方法 |
RU2699040C1 (ru) * | 2018-07-23 | 2019-09-03 | Федеральное государственное бюджетное учреждение науки "Уральский научно-практический центр радиационной медицины Федерального медико-биологического агентства" (ФГБУН УНПЦ РМ ФМБА России) | Способ экстренной профилактики и лечения острой лучевой болезни (варианты) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US5106841A (en) * | 1986-05-13 | 1992-04-21 | Chai-Tech Corporation | Antiviral compositions and method for their use |
US5223538A (en) * | 1987-03-31 | 1993-06-29 | Duke University | Superoxide dismutase mimic |
AU678139B2 (en) * | 1991-08-26 | 1997-05-22 | Research Corporation Technologies, Inc. | Method of enantio selectively epoxidizing cinnamate derivatives |
US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
-
1992
- 1992-12-07 US US07/987,474 patent/US5403834A/en not_active Expired - Lifetime
-
1993
- 1993-12-06 CA CA002150937A patent/CA2150937C/en not_active Expired - Fee Related
- 1993-12-06 SK SK745-95A patent/SK74595A3/sk unknown
- 1993-12-06 GB GB9415050A patent/GB2277873B/en not_active Expired - Fee Related
- 1993-12-06 AU AU57419/94A patent/AU697399B2/en not_active Ceased
- 1993-12-06 NZ NZ259200A patent/NZ259200A/en not_active IP Right Cessation
- 1993-12-06 WO PCT/US1993/011857 patent/WO1994013300A1/en active IP Right Grant
- 1993-12-06 KR KR10-2003-7004595A patent/KR20040004386A/ko not_active Application Discontinuation
- 1993-12-06 PL PL93309334A patent/PL175446B1/pl not_active IP Right Cessation
- 1993-12-06 CZ CZ0144295A patent/CZ296288B6/cs not_active IP Right Cessation
- 1993-12-06 GB GB9621087A patent/GB2305107B/en not_active Expired - Fee Related
- 1993-12-06 UA UA95062707A patent/UA27949C2/uk unknown
- 1993-12-06 JP JP51432894A patent/JP3502099B2/ja not_active Expired - Fee Related
- 1993-12-06 EP EP94903498A patent/EP0746321B1/en not_active Expired - Lifetime
- 1993-12-06 EP EP05005538A patent/EP1642583A2/en not_active Withdrawn
- 1993-12-06 HU HU9501644A patent/HU225109B1/hu not_active IP Right Cessation
- 1993-12-06 RU RU95116579/14A patent/RU2157213C2/ru not_active IP Right Cessation
- 1993-12-06 DE DE69333775T patent/DE69333775T2/de not_active Expired - Lifetime
- 1993-12-06 AT AT94903498T patent/ATE290867T1/de not_active IP Right Cessation
-
1995
- 1995-01-26 US US08/380,731 patent/US5827880A/en not_active Expired - Lifetime
- 1995-06-06 NO NO19952237A patent/NO319454B1/no not_active Application Discontinuation
- 1995-06-06 LV LVP-95-158A patent/LV10924B/en unknown
- 1995-06-06 OA OA60674A patent/OA10165A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10924A (lv) | Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai | |
CA2223510A1 (en) | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease | |
PT671910E (pt) | Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma | |
ATE328599T1 (de) | Antitumorale mittel | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
SE7502341L (lv) | ||
DE3875866D1 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
DK0983072T4 (da) | Fruktanholdige sammensætninger til forebyggelse og behandling af coloncancer | |
IE893618L (en) | Lactamimides in the treatment of drug-resistant protozoal¹infections | |
GB9400691D0 (en) | Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors | |
CA2033249A1 (en) | Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures | |
MX9301935A (es) | Compuestos para el tratamiento de alteraciones neurodegenerativas. | |
IS4198A (is) | Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða | |
GB9004348D0 (en) | New use of catechol derivatives and their physiologically acceptable salts and esters | |
NO874241D0 (no) | Terapeutisk aktive salter. | |
LV11593A (lv) | Dimetikona pielietojums aizcietejumu arstesana | |
DE69009765D1 (de) | Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE222255T1 (de) | 14-substituierte marcfortine und derivate als antiparasitäre mittel | |
EP0182569A3 (en) | Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages | |
IT1244360B (it) | Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale | |
UA10259A (uk) | Протинабряковий лікарський препарат "нейрополіосм" | |
IT1251993B (it) | Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico | |
YU104192A (sh) | 2-(4-hidroksipiperiodino)-1-alkanol derivati |